Cargando…
ZEB1 confers chemotherapeutic resistance to breast cancer by activating ATM
Although zinc finger E-box binding homeobox 1 (ZEB1) has been identified as a key factor in the regulation of breast cancer differentiation and metastasis, its potential role in modulating tumor chemoresistance has not been fully understood. Here, through the study of specimens from a large cohort o...
Autores principales: | Zhang, Xiang, Zhang, Zhen, Zhang, Qing, Zhang, Quansheng, Sun, Peiqing, Xiang, Rong, Ren, Guosheng, Yang, Shuang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5833408/ https://www.ncbi.nlm.nih.gov/pubmed/29352223 http://dx.doi.org/10.1038/s41419-017-0087-3 |
Ejemplares similares
-
ZEB1 confers stem cell-like properties in breast cancer by targeting neurogenin-3
por: Zhou, Chen, et al.
Publicado: (2017) -
ZEB1 induces ER-α promoter hypermethylation and confers antiestrogen resistance in breast cancer
por: Zhang, Jianbo, et al.
Publicado: (2017) -
ZEB1 Upregulates VEGF Expression and Stimulates Angiogenesis in Breast Cancer
por: Liu, Lingjia, et al.
Publicado: (2016) -
Jagged1-Notch1-deployed tumor perivascular niche promotes breast cancer stem cell phenotype through Zeb1
por: Jiang, Huimin, et al.
Publicado: (2020) -
CDK4/6 inhibition blocks cancer metastasis through a USP51-ZEB1-dependent deubiquitination mechanism
por: Zhang, Zhen, et al.
Publicado: (2020)